OR WAIT null SECS
July 13, 2021
The IND for Tevogen Bio's TVGN-489, an allogeneic COVID-19-specific cytotoxic T lymphocyte, received rapid clearance from FDA.
GEA’s plug-and-produce skids are designed for multi-product pharmaceutical and biopharmaceutical separation.
NewAge Industries is adding cleanrooms at its Pennsylvania headquarters.
July 12, 2021
AMRI reinforces positioning as a CDMO with name change and acquires the formulation and fill/finish company, Integrity Bio, and biologics company, LakePharma.
UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.
Purisys is now certified for ISO 17025 for testing and calibration laboratories and ISO 17034 for reference material producers
FDA’s review and approval of Aduhelm triggers controversy and a call for review from within the Agency.
July 09, 2021
Sparx Therapeutics will build its first commercial manufacturing facility in Yangzhou, China, for antibody drug production.
GlaxoSmithKline and Alector have partnered to co-develop two mAbs for a range of neurodegenerative diseases, including Parkinson’s and Alzheimer’s disease.
Univercells Technologies and VectorBuilder to produce custom viral vectors for cell and gene therapies as well as vaccine applications.